News Bigfoot Biomedical begins first artificial pancreas trial Trial will take place in three sites across the US.
News Medtronic to buy HeartWare, expand heart failure portfolio Deal worth an estimated $1.1 billion.
News New cystic fibrosis triple from Vertex backed for NHS use Vertex has won NICE's backing for a new cystic fibrosis therapy, Alyftrek, that could be an option for 89% of NHS patients with the genetic disorder.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face